1.5 C
Ottawa
Friday, April 4, 2025

Cancer-treatment developer CG Oncology files for IPO

Date:

Bladder-cancer treatment developer CG Oncology filed for an initial public offering with the Securities and Exchange Commission.

Thank you for reading this post, don't forget to subscribe!

The Irvine, Calif.-based biopharmaceutical company is developing a potential therapeutic for bladder-cancer patients who are unresponsive to immunotherapy Bacillus Calmette-Guerin treatment.

CG Oncology did not say how many shares it planned to offer or give an estimated price range. The company plans to use proceeds primarily for supporting operations.

The company has applied to list its shares on the Nasdaq Global Market under the ticker CGON.

Morgan Stanley, Goldman Sachs & Co., Cantor and Lifesci Capital are acting as the underwriters of the offering.

know more

Popular

More like this
Related

Paul Pogba second-worst among 53 Man Utd post-Fergie departees

The top seven all enjoyed their post-United success abroad, with an ex-England defender enjoying the best new lease of life.  During Sir Alex Ferguson’s reign, it used to be said that the only way was down after Manchester United . Which was probably true then. What about since Ferguson left? Here’s how we’ve ranked those

What we learned from Radio-Canada’s ‘Cinq chefs’ party leader interviews

French-speaking Canadians got a first taste of how the...

‘They make me always feel at home,’ says patient as Toronto’s SickKids Hospital marks 150 years

TorontoToronto's Hospital for Sick Children celebrated its 150th birthday...

Dairy producers dodge U.S. tariffs, but say there’s still a big battle ahead

8 hours agoNewsDuration 3:01The upcoming review of the Canada-US-Mexico...